![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Cepheid Obtains CE Mark for Rapid COVID-19 Combination Test
Cepheid Obtains CE Mark for Rapid COVID-19 Combination Test
![](https://www.fdanews.com/ext/resources/test/Device_Images/cepheid.gif?t=1451934383&width=430)
Cepheid has received CE mark certification for its Xpert Xpress SARS-CoV-2/flu/respiratory syncytial virus (RSV) rapid molecular diagnostic test.
The test uses a single patient sample to detect the viruses that cause COVID-19, influenza A/B and RSV infections, and delivers results in approximately 36 minutes.
The rapid four-in-one diagnostic is used on the company’s GeneXpert System. The system’s largest model can run up to 80 tests at a time and process approximately 2,000 tests daily, Cepheid said.
Upcoming Events
-
21Oct